Epitope mapping of prostate-specific antigen with monoclonal antibodies

Clinical Chemistry

Volumn 42, Issue 12, 1996, Pages 1961-1969

  Jette, Diane C ^a   Kreutz, Fernando T ^a   Malcolm, Bruce A ^a   Wishart, David S ^a   Noujaim, Antoine A ^b   Suresh, Mavanur R ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b Biomira   (Canada)

Author keywords

bacteriophage peptide library; immunoassay; prostate cancer

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN; ALPHA 2 MACROGLOBULIN; EPITOPE; KALLIKREIN; MONOCLONAL ANTIBODY; PROSTATE SPECIFIC ANTIGEN;

ANTIBODY SPECIFICITY; ANTIGEN ANTIBODY COMPLEX; ANTIGEN BINDING; ARTICLE; BACTERIOPHAGE; BINDING AFFINITY; CANCER SCREENING; COMPUTER MODEL; CROSS REACTION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; MALE; PEPTIDE ANALYSIS; PROSTATE CANCER;

EID: 0029826979     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/42.12.1961     Document Type: Article

References (40)

1. Watt KWK, Lee P, Timkulu TM, Chan W-P, Loor R. Human prostate-specific antigen: structural and functional similarity with serine proteases. Proc Natl Acad Sci U S A 1986;83:3166-70.
2. Schallar J, Akujama K, Tsuda R, Hara M, Marti T, Rickli B. Isolation, characterization and amino-acid sequence of γ-semino-protein, a glycoprotein from human seminal plasma. Eur J Biochem 1987;170:111-20.
3. Lundwall A, Lilja H. Molecular cloning of human prostate-specific antigen cDNA. FEBS Lett 1987;214:317-22.
4. Lilja H, Abrahamsson PA, Lundwall A. Seminogelin, the predominant protein in human seminal semen: primary structure and identification of closely related proteins in the male accessory sex glands and on the spermatozoa. J Biol Chem 1989;264:1894-900.
5. Akijama K, Nakamura T, Iwanaga S, Hara M. The chymotrypsin-like activity of human prostate-specific antigen, γsemino-protein. FEBS Lett 1987;225:168-72.
6. Christensson A, Laurell C-B, Lilja H. Enzymatic activity of the prostate-specific antigen and its reactions with extracellular serine proteinase inhibitors. Eur J Biochem 1990;194:755-63.
7. Drago JR, Badalament RA, Wientjes MG, Smith JJ, Nesbit JA, York JP, et al. Relative value of prostate-specific antigen and prostate acid phosphatase in diagnosis and management of adenocarcinoma of the prostate: Ohio State University experience. Urol 1989;34:187-92.
8. Catalona WJ, Smith DS, Raltief TL, Dodds KM, Coplen DE, Yuan JJ, et al. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. New Engl J Med 1991;324: 1156-61.
9. Schellhammer PF, Wright GL. Biomolecular and clinical characteristics of PSA and other candidate prostate tumor markers. Urol Clin North Am 1993;20:597-606.
10. Crawford ED, DeAntoni EP. PSA as a screening test for prostate cancer. Urol Clin North Am 1993;20:637-46.
11. Andriole GL, Catalona WJ. Using PSA to screen for prostate cancer: the Washington University experience. Urol Clin North Am 1993;20:647-52.
12. Lilja H. A kallikrein-like serine protease in prostatic fluid cleaves the seminal vesicle protein. J Clin Invest 1985;76:1899-903.
13. Schaller J, Akiyama K, Tsuda R, Hara M, Marti T, Rickli EE. Isolation, characterization, and amino-acid sequence of gamma-seminoprotein, a glycoprotein from human seminal plasma. Eur J Biochem 1987;170:111-20.
14. Reigman PH, Vlietstra RJ, Suurmeifer L, Cleutjens CB, Trapman J. Characterization of the human kallikrein locus. Genomics 1992; 14:6-11.
15. Berg T, Bradshaw R, Carretero O, Chao J, Chao L, Clements J. A common nomenclature for members of the tissue (glandular) kallikrein gene families. Recent progress on kinins. Agents Actions 1992;38(Suppl 1):19-25.
16. Carbini I, Scicli A, Carretero O. The molecular biology of the kallikrein-kinin system; III. The human gene family and kallikrein substrate. J Hypertens 1993;11:893-8.
17. Chung DW, Fujikawa K, McMullen BA, Davie EW. Human plasma prekallikrein, a zymogen to a serine protease that contains four tandom repeats. Biochemistry 1986;25:2410-7.
18. Clements J. The kallikrein gene family: a diversity of expression and function. Mol Cell Endocrinol 1994;99:C1-C6.
19. McCormack RT, Rittenhouse HG, Finlay JA, Sokoloff RL, Wang TJ, Wolfert RL, et al. Molecular forms of prostate-specific antigen and the human kallikrein gene family: a new era. Urology 1995;45: 729-44.
20. Jensen-Scottrup L. α-Macroglobulins: structure, shape, and mechanism of proteinase complex formation. J Biol Chem 1989;264: 11539-42.
21. Stenman U-H, Leinonen J, Alfthan H, Rannikko S, Tuhkanen K, Alfthan O. A complex between prostate-specific antigen and α1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostate cancer: assay of the complex improves clinical sensitivity for cancer. Cancer Res 1991;51: 222-6.
22. 1-antichymotrypsin. Clin Chem 1991;37:1618-25.
23. Christensson A, Bjork T, Nilsson O, Dahlen U, Matakainen M-T, Cockett ATK, et al. Serum prostate-specific antigen complexed to α1-antichymotrypsin as an indicator of prostate cancer. J Urol 1993;150:100-5.
24. Graves HCB. Standardization of immunoassays for prostate-specific antigen. Cancer 1993;72:3141-4.
25. Zhou AM, Tewari PC, Bluestein BI, Caldwell GW, Larson FI. Multiple forms of prostate-specific antigen in serum: differences in immunorecognition by monoclonal and polyclonal assays. Clin Chem 1993;39:2483-91.
26. Jurince-Winkler C, von der Kammer H, Horlbeck R, Klippel K-F, Pixberg HU, Scheit K-H. Clinical evaluation of a new prostate-specific antigen sandwich ELISA which employs four monoclonal antibodies directed at different epitopes of prostate-specific antigen. Eur Urol 1993;24:487-91.
27. Vessella RL, Lange PH. Issues in the assessment of PSA immunoassays. Urol Clin North Am 1993;20:607-19.
28. Vessella RL. Trends in immunoassays of prostate-specific antigen: serum complexes and ultrasensitivity [Editorial]. Clin Chem 1993;39:2035-9.
29. Jolley NL, Bacarese-Hamilton T. SR1™ assay of α-fetoprotein, carcino-embryonic antigen, and prostate-specific antigen compared with corresponding established commercial assays. Clin Chem 1994;40:895-9.
30. Cattini R, Robinson CR, Jolley GO, Bacarese-Hamilton T. Measurement of prostate-specific antigen in serum using four different immunoassays. Eur J Clin Chem Clin Biochem 1994;32:181-5.
31. Kreutz FT, Suresh MR. Bispecific monoclonal antibodies in immunodiagnostics of prostate cancer. Fourth International Conference on bispecific monoclonal antibodies and targeted cellular toxicity Proceedings, 1995. Hawk's Key, FL:17.
32. Christian RB, Zuckermann RN, Kerr JM, Wang L, Malcolm BA. Simplified methods for construction, assessment and rapid screening of peptide libraries in bacteriophage. J Mol Biol 1992; 227:711-8.
33. Wishart DS, Boyko RF, Willard L, Richards FM, Sykes BD. SEQSEE: a comprehensive program suite for protein sequence analysis. Comput Appl Biosci 1994;10:121-32.
34. Vijinen M. Modelling of prostate specific antigen and human glandular kallikrein structures. Biochem Biophys Res Commun 1994;204:1251-6.
35. Bridon D, Dowell B. Structural comparison of prostate-specific antigen and human glandular kallikrein using molecular modeling. Urology 1995;45:801-6.
36. Wu JT, Zhang P, Wang T, Wilson L, Astill M. Evaluation of free PSA isoforms, PSA complex formation and specificity of anti-PSA antibodies by HPLC and PAGE-immunoblotting techniques. J Clin Lab Anal 1995;9:1-14.
37. Geyson HM, Meloen RH, Barteling SJ. Use of peptide synthesis to probe viral antigens for epitopes to a resolution of a single amino acid. Proc Natl Acad Sci U S A 1984;81:3998-4002.
38. Scott JK, Smith GP. Searching for peptide ligands with an epitope library. Science 1990;249:386-90.
39. Cwirla SE, Peters EA, Barrette RW, Dower UI. Peptides on phage: a vast library of peptides for identifying ligands. Proc Natl Acad Sci USA 1990;87:6378-82.
40. Devlin JJ, Panganiban LC, Devlin PE. Random peptide libraries: a source of specific protein binding molecules. Science 1990;249: 404-6.